OXGN this is a $10 stock on the works imo. "Showing superior effectiveness, effect on serious outcomes or improved effect on serious outcomes Avoiding serious side effects of an available therapy Improving the diagnosis of a serious condition where early diagnosis results in an improved outcome Decreasing a clinical significant toxicity of an available therapy that is common and causes discontinuation of treatment Ability to address emerging or anticipated public health need"